nifedipine has been researched along with losartan potassium in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bell, LL; Brauneis, U; Cheung, JY; Elensky, MB; Miller, BA; Scaduto, RC; Tillotson, DL | 1 |
Belch, JJ; McLaren, M; Stewart, WK; Taylor, JE | 1 |
Alcazar, JM; Andrés, A; Fernández, G; Hernández, E; Morales, JM; Ortuño, B; Praga, M; Rodicio, JL | 1 |
Allegra, A; Aloisi, C; Baldari, S; Buemi, M; Imbesi, D; Laganà, A; Morabito, N; Palella, S; Privitera, M; Villari, C | 1 |
Cho, BH; Kang, SK; Kim, JH; Kim, SH; Park, SK; Rhee, SR | 1 |
Belch, JJ; Henderson, IS; Stewart, WK; Taylor, JE | 1 |
Albitar, S; Bourgeon, B; Fen-Chong, M; Genin, R; Serveaux, MO | 1 |
Akimoto, T; Amemiya, M; Ando, Y; Asano, Y; Inoue, M; Ito, C; Kusano, E; Yanagiba, S | 1 |
4 trial(s) available for nifedipine and losartan potassium
Article | Year |
---|---|
Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
Topics: Captopril; Creatinine; Erythropoietin; Female; Follow-Up Studies; Hematocrit; Hemoglobins; Humans; Kidney Transplantation; Male; Nifedipine; Polycythemia; Postoperative Complications; Potassium; Time Factors | 1995 |
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation?
Topics: Adult; Blood Circulation; Calcium; Erythropoietin; Gallopamil; Humans; Ketanserin; Male; Nifedipine; Recombinant Proteins; Vasoconstrictor Agents; Verapamil | 1994 |
Preventive effect of enalapril on erythrocytosis after renal transplantation.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Enalapril; Erythropoietin; Female; Hematocrit; Humans; Kidney Transplantation; Male; Nifedipine; Polycythemia; Postoperative Complications; Retrospective Studies; Time Factors | 1996 |
High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Erythropoietin; Female; Humans; Male; Middle Aged; Nifedipine; Prospective Studies; Recombinant Proteins; Renal Dialysis | 1998 |
5 other study(ies) available for nifedipine and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Ion channels in human erythroblasts. Modulation by erythropoietin.
Topics: Adult; Calcium; Erythroblasts; Erythropoietin; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Ion Channels; Nifedipine; Potassium Channels | 1992 |
Effect of nifedipine on changes in fibrinogen and von Willebrand factor in haemodialysis patients treated with recombinant human erythropoietin.
Topics: Erythropoietin; Fibrinogen; Humans; Nifedipine; Recombinant Proteins; Renal Dialysis; Risk Factors; von Willebrand Factor | 1995 |
Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin.
Topics: Anemia; Antihypertensive Agents; Blood Flow Velocity; Calcium Channel Blockers; Case-Control Studies; Erythropoietin; Female; Fingers; Humans; Hyperemia; Kidney Failure, Chronic; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Nifedipine; Recombinant Proteins; Renal Dialysis; Skin | 1996 |
Involvement of erythropoietin-induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells.
Topics: Animals; Calcium; DNA; Enzyme Activation; Erythropoietin; Genistein; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Naphthalenes; Nifedipine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Erythropoietin; Recombinant Proteins | 2001 |